Open AccessEssential updates to the surgical treatment of biliary tract cancer
Author(s) -
Matsukuma Satoshi,
Tokumitsu Yukio,
Shindo Yoshitaro,
Matsui Hiroto,
Nagano Hiroaki
Publication year - 2019
Publication title -
annals of gastroenterological surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.308
H-Index - 15
ISSN - 2475-0328
DOI - 10.1002/ags3.12266
Subject(s) - medicine , biliary tract cancer , gallbladder cancer , biliary tract , bile duct cancer , pancreatic cancer , perioperative , general surgery , cancer , chemotherapy , adjuvant chemotherapy , intrahepatic cholangiocarcinoma , bile duct , surgery , gemcitabine , breast cancer
Biliary tract cancer, which includes intrahepatic cholangiocarcinoma, extrahepatic bile duct cancer, gallbladder cancer, and ampullary cancer, is an intractable disease with a dismal prognosis. Prognosis is particularly poor in cases involving vessels or lymph nodes. Hepatobiliary pancreatic surgeons worldwide have consistently focused on improving surgical treatment, perioperative management, and chemotherapy to improve the outcomes of these diseases. There has been significant progress even in the last 2 years (2017 and 2018), such as promising findings reported by studies on the optimal extent of surgical treatment and multi‐institutional randomized controlled trials on adjuvant chemotherapy. We overview the current trends and advancements made in surgical treatment in 2017 and 2018.